Skip to main content

Flammer Martina M.D.'s Form 4 filing

INSMED IncINSM · filed Feb 4, 2026

Accession no.
0001796960-26-000008
Filed
Feb 4, 2026
Trade date
Feb 2-3, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.36M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Flammer Martina M.D.CIK 0001796960Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 2, 2026Common StockMOption exerciseAcquired+7,982$65.72+$524,577.0492,889Direct
Feb 2, 2026Common StockSSaleDisposed−563$152.06F2−$85,609.7892,326Direct
Feb 2, 2026Common StockSSaleDisposed−928$153.16F3−$142,132.4891,398Direct
Feb 2, 2026Common StockSSaleDisposed−3,349$154.56F4−$517,621.4488,049Direct
Feb 2, 2026Common StockSSaleDisposed−3,042$155.46F5−$472,909.3285,007Direct
Feb 2, 2026Common StockSSaleDisposed−100$156.86−$15,68684,907Direct
Feb 3, 2026Common StockSSaleDisposed−795$155.77−$123,837.1584,112Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 2, 2026Common StockMOption exerciseDisposed−7,982$0.00$023,948Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This is the weighted average sales price representing 563 shares sold at prices ranging from $151.76 to $152.74 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F3

This is the weighted average sales price representing 928 shares sold at prices ranging from $152.77 to $153.31 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F4

This is the weighted average sales price representing 3,349 shares sold at prices ranging from $154.10 to $155.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F5

This is the weighted average sales price representing 3,042 shares sold at prices ranging from $155.10 to $155.96 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)